Moreover, experimental knock-down of CD24 expression in human bladder cancer cell lines reduced sphere formation, sensitivity to cisplatin-induced apoptosis, reduced the expression of the tumor stem-cell marker CD133, and attenuated tumor growth in an in vivo cancer model [26]. This evidence concerns the gene CD24 and urinary bladder carcinoma.